Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-27.94	86.27	119.71
Graham Fair Price	13.78	28.23	24.81
PEG	-57.78	1.88	-4.46
Price/Book	-11.15	15.86	17.85
Price/Cash Flow	-35.08	167.45	257.93
Prices/Earnings	-20.60	36.95	46.53
Price/Sales	-8.62	32.77	35.86
Price/FCF	-35.08	167.45	257.93
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.81	0.51	0.49
Operating Margin	50.39	0.28	0.18
ROA	11.46	0.04	0.04
ROE	0.10	0.11	11.90
ROIC	0.04	0.06	64.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	-0.03	130.63
Dividends QOQ	-0.94	-1.00	-6.49
EBIT QOQ	-0.37	0.56	51.63
EPS QOQ	-0.10	0.20	88.05
FCF QOQ	-0.29	0.46	62.74
Revenue QOQ	-0.01	0.04	200.79
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	109.47	114.33	4.44
Days Sales Outstanding (DSO)	105.73	106.74	0.95
Inventory Turnover	0.82	0.79	-4.25
Debt/Capitalization	0.51	0.45	-12.10
Quick Ratio	2.60	2.80	7.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.89	18.17	7.56
Cash	6.22	7.64	22.78
Capex	-1.74	-1.08	38.04
Free Cash Flow	1.17	1.72	47.21
Revenue	8.41	8.79	4.58
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.56	3.87	8.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.90	2.04	-29.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating